Abiopharma

Arcos Dorados Reports Second Quarter 2026 Financial Results

Mobix Labs Signs Definitive Rare Earth Elements Deal, Expanding National Security Platform; Hosts Investor Call Today at 4:15pm ET

Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

New Form SCHEDULE 13G/A - Concentrix Corp <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000183 <b>Size:</b> 8 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000950103-26-012290 <b>Size:</b> 260 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023640 <b>Size:</b> 1 MB

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G/A - Chewy, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000182 <b>Size:</b> 8 KB

Pelthos Therapeutics Announces Second Quarter 2026 Financial Results

Change - Announcement of Cessation: Cessation of Group Chief Operating Officer

Change - Announcement of Appointment: Appointment of Group Chief Operating Officer

New Form SCHEDULE 13G/A - BELLRING BRANDS, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000181 <b>Size:</b> 8 KB

New Form N-PX - AMES NATIONAL CORP <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001132651-26-000001 <b>Size:</b> 110 KB

General Announcement: Appointment of Group Chief Operating Officer

Charlotte's Web Reports Second Quarter 2026 Financial Results